The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects-Reference-Cited by-同舟云学术

The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

Published:2007-12 Issue:6 Volume:9 Page:467-474
ISSN:1523-3812
Container-title:Current Psychiatry Reports
language:en
Short-container-title:Curr Psychiatry Rep

Author:

Maeng Sungho,Zarate Carlos A.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11920-007-0063-1.pdf

Reference58 articles.

1. Fagiolini A, Kupfer DJ, Masalehdan A, et al.: Functional impairment in the remission phase of bipolar disorder. Bipolar Disord 2005, 7:281–285.

2. Huxley N, Baldessarini RJ: Disability and its treatment in bipolar disorder patients. Bipolar Disord 2007, 9:183–196.

3. Rush AJ, Trivedi MH, Wisniewski SR, et al.: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905–1917.

4. Trivedi MH, Rush AJ, Wisniewski SR, et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28–40.

5. Manji HK, Moore GJ, Rajkowska G, Chen G: Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000, 5:578–593.

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electroconvulsive therapy combined with esketamine improved depression through PI3K/AKT/GLT-1 pathway;Journal of Affective Disorders;2024-09

2. REVOLUTIONIZING DEPRESSION TREATMENT: A PARADIGM SHIFT OF KETAMINE THERAPY – A SYSTEMATIC REVIEW;Asian Journal of Pharmaceutical and Clinical Research;2024-08-07

3. Delineating the molecular mechanisms of hippocampal neurotoxicity induced by chronic administration of synthetic cannabinoid AB-FUBINACA in mice;NeuroToxicology;2024-07

4. Mapping Changes in Glutamate with Glutamate-Weighted MRI in Forced Swim Test Model of Depression in Rats;Biomedicines;2024-02-07

5. Temporal dynamics of BDNF signaling recruitment in the rat prefrontal cortex and hippocampus following a single infusion of a translational dose of ketamine;Neuropharmacology;2024-01